These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7696800

  • 1. MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP.
    Coley BD, Mattrey RF, Baker KG, Peterson T, Burgan AR.
    J Magn Reson Imaging; 1995; 5(1):11-6. PubMed ID: 7696800
    [Abstract] [Full Text] [Related]

  • 2. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B, Vogl TJ, Branding G, Schnell B, Taupitz M, Wolf KJ, Lissner J.
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [Abstract] [Full Text] [Related]

  • 3. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
    Young SW, Simpson BB, Ratner AV, Matkin C, Carter EA.
    Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
    [Abstract] [Full Text] [Related]

  • 4. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
    Rofsky NM, Weinreb JC.
    Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
    [Abstract] [Full Text] [Related]

  • 5. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
    Birnbaum BA, Weinreb JC, Fernandez MP, Brown JJ, Rofsky NM, Young SW.
    Clin Imaging; 1994 Sep; 18(1):21-7. PubMed ID: 8180855
    [Abstract] [Full Text] [Related]

  • 6. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ, Hamm B, Schnell B, McMahon C, Branding G, Lissner J, Wolf KJ.
    J Magn Reson Imaging; 1993 Sep; 3(1):51-8. PubMed ID: 8381314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
    Bernardino ME, Young SW, Lee JK, Weinreb JC.
    Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
    [Abstract] [Full Text] [Related]

  • 9. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients.
    Aicher KP, Laniado M, Kopp AF, Grönewäller E, Duda SH, Claussen CD.
    J Magn Reson Imaging; 1993 Apr; 3(5):731-7. PubMed ID: 8400558
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
    Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME.
    Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
    [Abstract] [Full Text] [Related]

  • 11. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
    Suto Y, Weinreb JC, Rofski NM.
    J Comput Assist Tomogr; 1996 Jul; 20(4):647-9. PubMed ID: 8708073
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T, Baron RL, Peterson MS, Oliver JH, Davis PL, Confer SR, Federle MP.
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [Abstract] [Full Text] [Related]

  • 13. Adrenal gland enhancement at MR imaging with Mn-DPDP.
    Mitchell DG, Outwater EK, Matteucci T, Rubin DL, Chezmar JL, Saini S.
    Radiology; 1995 Mar; 194(3):783-7. PubMed ID: 7862979
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis.
    Tanimoto A, Kreft BP, Baba Y, Zhao L, Finn JP, Compton CC, Stark DD.
    J Magn Reson Imaging; 1993 Mar; 3(5):786-93. PubMed ID: 8400566
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    Kettritz U, Warshauer DM, Brown ED, Schlund JF, Eisenberg LB, Semelka RC.
    Eur Radiol; 1996 Mar; 6(1):14-8. PubMed ID: 8797944
    [Abstract] [Full Text] [Related]

  • 16. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM, Earls JP.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [Abstract] [Full Text] [Related]

  • 17. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
    Gong J, Xu J, Zhou K, Shen K.
    Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
    [Abstract] [Full Text] [Related]

  • 18. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
    Gehl HB, Urhahn R, Bohndorf K, Klever P, Hauptmann S, Lodemann KP, Matern S, Schumpelick V, Günther RW.
    Radiology; 1993 Mar; 186(3):795-8. PubMed ID: 8430190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.